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ABSTRACT 
Due to high relative blood flow the kidney is prone to drug-induced damage. Aminoglycoside type antibiotic 
gentamicin is one of the leading cause of drug-induced nephrotoxicity. In recent years gentamicin nephrotoxicity 
is significantly reduced by shifting to once daily dosage as well as by eliminating known risk factors. Application 
of gentamicin is still related to serious side effects which are reported more often compared to other antibiotics. 
Because gentamicin is still heavily used and is highly efficient in treating infections, it is important to find mech-
anisms to reduce its nephrotoxicity. This aim can only be achieved through better understanding of kidney metab-
olism of gentamicin. This problem has been extensively researched in the last 20 years. The experimental results 
have provided evidence for almost complete understanding of mechanisms responsible for gentamicin nephrotox-
icity. We now have well described morphological, biochemical and functional changes in kidney due to gentamicin 
application. During the years, this model has become so popular that now it is used as an experimental model for 
nephrotoxicity per se. This situation can mislead an ordinary reader of scientific literature that we know everything 
about it and there is nothing new to discover here. But quite opposite is true. The precise and complete mechanism 
of gentamicin nephrotoxicity is still point of speculation and an unfinished story. With emerge of new and versatile 
technics in biomedicine we have an opportunity to reexamine old beliefs and discover new facts. This review 
focuses on current knowledge in this area and gives some future perspectives. 
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INTRODUCTION 
Due to relatively large blood flow (20 % 
of stroke volume) and the ability to extract 
and concentrate hydrosoluble toxic molecu-
les, the kidney is prone to drug induced da-
mage. The experimental data point to the fact 
that drug induced nephrotoxicity includes 
multiple mechanisms that can be classified as 
vascular, glomerular and tubular. The kidney 
damage is usually a consequence of tubular 
obsruction caused by cell swelling or debris 
deposition (Perazella, 2003). Toxic sub-
stances can damage various cell types in kid-
ney. The most studied effect is necrosis of 
tubular epithelial cells. There is also a de-
scription of morphological glomerular dam-
age with reduced function (Stojiljkovic et al., 
2012). The application of some drugs (gen-
tamicin, cisplatin) to experimental animals is 
causing significant reduction in kidney blood 
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flow and glomerular filtration with increase in 
vascular resistance. These effects can be pre-
sent without permanent morphological 
changes in glomerulus and independent from 
tubular damage (Bennett et al., 1994).  
 
Tubular effects 
Gentamicin (GM) is causing tubular dam-
age through: 1) necrosis of tubular epithelial 
cells, predominantly in proximal segment and 
2) alteration of function of main cellular com-
ponents involved in transport of water and so-
lutes. The central aspect of GM nephrotoxi-
city is tubular cytotoxicity. The treatment of 
animals with GM is related to apoptosis (El 
Mouedden et al., 2000; Li et al., 2009) as well 
as necrosis of tubular epithelial cells (Ed-
wards et al., 2007). In cell culture, GM is also 
causing apoptosis (El Mouedden et al., 2000) 
as well as necrosis of those cells (Pessoa et al., 
2009). Gentamicin is causing cytotoxicity in 
the cells where it accumulates. In kidney, 
those are usually epithelial cells of proximal 
tubules (Verpooten et al., 1989) while cells of 
distal tubules and collecting ducts are signifi-
cantly less affected by cytotoxic effects (Fuji-
wara et al., 2009). The increased accumula-
tion of GM in proximal tubules is related to 
expression of transport molecule for proteins 
and cations (megalin and cubilin complex) in 
proximal tubules. It is known that this com-
plex is responsible for transport of GM by en-
docytosis (Sassen et al., 2006). The drug is 
then transported to lysosomes, Goldzi appa-
ratus and endoplasmic reticulum (Silverblatt, 
1982). Gentamicin binds to membrane phos-
pholipids, alters its function and lead to a con-
dition known as phospholipidosis in humans 
(De Broe et al., 1984) and experimental ani-
mals (Nonclercq et al., 1992). Lysosomal 
phospholipidosis is caused by: disorder in 
phosphatidylinositol signaling pathway 
(Ramsammy et al., 1988), reduced turnover of 
phospholipids and their accumulation in 
plasma membrane (Laurent et al., 1982), de-
crease in the available negative charge for 
proper function of phospholipases (Mingeot-
Leclercq et al., 1995), inhibition of calcium 
dependent phosphodiesterases (Van Rooijen 
and Agranoff, 1985) and by inhibition of 
phospholipases A1, A2 and C1 (Abdel-Gay-
oum et al., 1993). Phospholipidosis is directly 
related to toxicity of GM (Kaloyanides, 
1992). However, similar changes were de-
tected in other cell types exposed to GM but 
without significant damage and cellular death. 
We can conclude that these effects are not im-
portant to toxicity in epithelial cells. When 
concentration of GM in endosomes reaches 
certain level, their membranes disrupts and 
their content including GM is released to cy-
toplasm (Regec et al., 1989). In cytoplasm 
GM acts on mitochondria both directly and 
indirectly (Morales et al., 2010) and activates 
intrinsic apoptosis pathway, breaks respira-
tory chain, decrease ATP synthesis and leads 
to oxidative stress by creating superoxide an-
ion and hydroxyl radical (Cuzzocrea et al., 
2002) resulting in cell death. Indirect mito-
chondrial effect is mediated by increased lev-
els of Bcl-2 associated protein X (Bax) 
(Horibe et al., 2004) through inhibition of its 
degradation in proteasomes (Servais et al., 
2006). Lysosomal content is made of highly 
active proteases called cathepsins capable of 
inducing cell death (Schnellmann and Wil-
liams, 1998). Cathepsin induced cell death is 
performed through apoptosis mechanism by 
direct activation of executive caspases and in-
directly by proteolitic activation of proapop-
totic protein Bid and intrinsic pathway (Yin, 
2006). When present in large quantities, ca-
thepsins cause massive proteolysis which re-
sults in necrosis, especially in the lack of ATP 
(Golstein and Kroemer, 2007). Inside endo-
plasmic reticulum, GM inhibits protein syn-
thesis, disrupts translation accuracy and post-
translation modification of proteins (Horibe et 
al., 2004). This results in endoplasmic reticu-
lum stress and activation of apoptosis by 
caspase 12 and calpain (Peyrou et al., 2007). 
Finally, it is documented that activation of ex-
tracellular calcium receptor (CaSR) by GM 
also induce milder degree of apoptosis in cells 
of tubules with CaSR but also in those who 
lacks it. On the other hand, CaSR is found on 
GM resistant cells like bone cells, neurons, 
smooth muscle cells, endothelial cells etc. So 
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we still need more information about the pre-
cise role of CaSR in GM-induced nephrotox-
icity. 
In cell culture experiments it was shown 
da GM inhibits a number of membrane trans-
port proteins, independently of cell damage 
(Sassen et al., 2006). Inhibition of transport 
disrupts reabsorption in tubules and threatens 
cell homeostasis. For example, sodium-potas-
sium pump is key component in regulation of 
cell volume. Inhibition of this pump would 
produce cell swelling and consequential ne-
crosis or apoptosis (Lieberthal and Levine, 
1996). As soon as after 30 minutes of perfu-
sion of kidney with GM or 3 hours after ap-
plication to animals, reduced kidney calcium 
and magnesium uptake is seen, leading to in-
creased excretion of this minerals through 
kidney, before visible signs of damage (Par-
sons et al., 1997). Gentamicin is transported 
and competes with proteins, cations and other 
molecules for megalin-cubilin complex in 
proximal tubules and interferes with their re-
absorption. 
The damaged tissue or cells is released 
into the lumen of the tubules and leads to par-
tial or complete obstruction resulting in de-
crease of excretory function (Rivas-Cabanero 
et al., 1993). The present obstruction in-
creases the hydrostatic pressure in tubules and 
Bowman’s capsule which leads to decrease in 
filtration pressure and glomerular filtration. 
However, in the beginning of this process, 
when there is no significant tubular obstruc-
tion, we can detect a rise in serum levels of 
urea and creatinine, pointing to reduction in 
glomerular filtration. In the absence of 
marked obstruction of the nephron, the ob-
served increase in plasma creatinine level can 
only be explained by reduction in glomerular 
filtration. Structural damage of the tubules 
leads to impairment of reabsorption causing 
overflow of water and solutes into the distal 
parts of nephron, activating tubuloglomerular 
feedback loop. This physiological mechanism 
is accomplished by angiotensin II and afferent 
and efferent arteriole, resulting in decrease in 
glomerular filtration (Blantz et al., 2007). 
This feedback is activated as a protective 
mechanism to prevent great loss of water and 
solutes (Komlosi et al., 2009). This mecha-
nism is fully adapted in 24 hours period (Deng 
et al., 2004). So, after that time its role in fil-
tration decrease should be absent in physio-
logical conditions. Nevertheless, the filtration 
in glomerulus remains low as long as GM is 
present. One of the possible explanations is 
that present oxidative stress, inflammation 
and release of vasoconstrictor substances give 
rise to constriction of mesangial cells and 
blood vessels.  
There are two main factors for kidney 
damage induced by GM: its accumulation in 
proximal tubular cells and interaction with 
cell membranes and organelles. The cells of 
brush border are exposed to concentration of 
GM higher than the one in serum because kid-
ney is main excretory organ for GM. There is 
evidence that the concentration of GM in cells 
of proximal tubules is not related to ne-
phrotoxicity, although tubular necrosis is dose 
dependent (Bennett, 1989). Recent in vitro 
studies showed that the key aspect of GM cy-
totoxicity is its concentration in cytoplasm, 
not accumulation in lysosomes as thought ear-
lier (Servais et al., 2008). Also it was proved 
that small amount of GM directly enters the 
cytoplasm, independently of megalin-cubilin 
mediated endocytosis (Myrdal et al., 2005). 
Besides, it was demonstrated that GM can en-
ter the cells of tubules in vitro through non-
specific cationic channel TRPV4 (Karasawa 
et al., 2008). However, this channel is present 
only in distal tubules and its contribution to 
GM cell entry is small. 
Gentamicin is actively eliminated by glo-
merular filtration. Around 3 to 5 % from en-
tered GM is actively reabsorbed in proximal 
tubules cells (Laurent et al., 1990) and cause 
necrosis of S1-S2 segment of proximal tu-
bules (Houghton et al., 1976). The accumula-
tion of undigested phospholipids in lyso-
somes is tightly related to GM nephrotoxicity. 
The concentration of GM in lysosomes can be 
shown by autoradiography (Silverblatt and 
Kuehn, 1979) or by labeled gold (Beauchamp 
et al., 1991). In both humans and animals, ly-
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sosomal phospholipidosis results in cell ne-
crosis and alterations in epithelial cells of 
proximal tubules and to a lesser extent in dis-
tal tubules and collecting ducts. Cojocel et al. 
(1984a) has shown that GM decrease level of 
glomerular filtration, as well as tubular reab-
sorption, leading to accumulation of low mo-
lecular weight proteins along with increased 
renal excretion of sodium and potassium. In 
physiological conditions these proteins are 
freely filtered in glomerulus and completely 
reabsorbed in tubules. Acidic environment 
enhance electrostatic interactions between 
GM and negatively charged phospholipids. 
Gentamicin easily binds to negatively 
charged lysosomal phospholipids because of 
highly acidic environment. The presence of 
this negatively charged phospholipids 
stimulates degradation of phosphatidyl-
choline by acid sphingomyelinase, phospho-
lypase A1, A2 and lipophospholypase 
(Laurent et al., 1990). However, it is not clear 
is the catabolism of other lipids altered in sim-
ilar manner. The intensity of phospholipids 
degradation is reduced in proximal tubules in 
the presence of GM (Laurent et al., 1990). 
This inhibitory effect of GM on phospho-
lipases is being accompanied with the pres-
ence of myeloid bodies (Laurent et al., 1982). 
In experimental animals and humans too the 
noted increase of phospholipids in kidney cor-
tex and phospholipiduria are related to lyso-
somal damage (Ibrahim et al., 1989). The ac-
cumulated phospholipids in lysosomes dis-
turb the homeostasis of the cell and initiates 
burst of organelles with release of toxic com-
ponents including GM. It was shown that 
poly-L-aspartic acid (PAA) can prevent lyso-
somal phospholipidosis caused by GM as well 
as signs of nephrotoxicity (Beauchamp et al., 
1990). The nephrotoxicity is reversible pro-
cess. Stopping of GM treatment is followed 
with regeneration of kidney epithelia. The 
glomerular filtration is changed only when 
over 30 % of proximal tubules are necrotic 
(Kourilsky et al., 1982). The reduced kidney 
function is seen when regeneration process 
can not compensate tissue damage cause by 
toxic agent.  
 
Glomerular effects 
The glomerulus is the first part of nephron 
that comes in contact with GM. Multiple 
mechanisms are responsible for filtration 
changes. Gentamicin is causing mesangial 
contraction and reducing glomerular filtration 
(Martinez-Salgado et al., 2007). Gentamicin 
also stimulates proliferation of mesangial 
cells followed by compensatory increase in 
apoptosis of those cells (Martinez-Salgado et 
al., 2007). Although GM does not cause mor-
phological changes in glomerulus, it was 
shown that high doses of GM are causing mild 
enlargement of glomeruli, change in circular 
shape and density with neutrophil infiltration 
(Stojiljkovic et al., 2008). The loss of selec-
tivity of filtration membrane leads to pro-
teinuria, especially in situation of reduced re-
absorption as seen in tubular necrosis (De-
Barros-e-Silva et al., 1992). Earlier studies 
showed that GM decrease number and size of 
pores on endothelial cells in glomerulus caus-
ing reduction in filtration (Cojocel et al., 
1984b). Those effects are a consequence of 
mesangial contraction. Gentamicin activates 
contraction of mesangial cells in culture and 
decrease filtration (Martinez-Salgado et al., 
1997). The mesangial contraction could be 
mediated by several mechanisms: secretion of 
platelet activating factor (PAF) (Rodriguez-
Barbero et al., 1995), activation of renin-an-
giotensin system, production of vasoconstric-
tor substances like endothelin-1 and throm-
boxane A2 (Valdivielso et al., 1999), stimula-
tion of CaSR and increase in reactive oxygen 
species (ROS) and oxidative stress (Duque et 
al., 1992). The activation of phospholipase 
A2 is related to synthesis of some of the men-
tioned mediators and with GM effect on 
mesangial cells (Martinez-Salgado et al., 
1997). Phospholipase A2 catalyze production 
of arachidonic acid and thromboxane A2 
leading to mesangial contraction. Platelet ac-
tivating factor is important mediator of 
mesangial contraction (Santos et al., 2009). 
Blocking the effect of PAF results in lack of 
mesangial contraction and decrease in filtra-
tion caused by GM (Rodriguez-Barbero et al., 
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1997). It seems that in vitro GM-induced cell 
proliferation is cell-specific. Some authors 
described that GM in in vitro conditions de-
crease proliferation of human epidermal 
keratinocyte, probably through inhibition of 
transport RNA (Tekos et al., 2003). Also GM 
inhibits cell proliferation in the organ of Corti 
and cells similar to human osteoblasts (Berto-
laso et al., 2003). The observed differences in 
GM effects on various cell is probably de-
pendent on drug concentration as well as ex-
perimental conditions.  
The experimental data are showing that 
O2- is involved in apoptosis of mesangial cells 
caused by GM, because system xanthine and 
xanthine oxidase increase apoptosis similar to 
GM. Moreover, scavengers of ROS, superox-
ide dismutase (SOD) and catalase, inhibits 
GM induced apoptosis (Martinez-Salgado et 
al., 2004). A lot of evidence points to the fact 
that stimulation of oxidative stress leads to 
apoptotic response in mesangial cells (Ishi-
kawa and Kitamura, 2000). Apoptosis of glo-
merular and tubular cells caused by interleu-
kin 1α and tumor necrosis factor α (TNF-α) is 
mediated by ROS (Bohler et al., 2000). Re-
garding this, O2- is proposed as selective me-
diator of mesangial cell apoptosis caused by 
TNF-α (Moreno-Manzano et al., 2000). 
Apoptosis of mesangial cells induced by GM 
is also characterized by early increase in 
proapoptotic protein Bax and late increase in 
antiapoptotic Bcl-2 protein (Martınez-Sal-
gado et al., 2004). Upregulation of Bcl-2 ex-
pression is also noted in cells of ovaries in re-
sponse to geneticin (Tey et al., 2000). Bcl-2 is 
found at sites of ROS production and is re-
sponsible for prevention of oxidative damage. 
It was shown that overexpression of Bcl-2 has 
protective effect on oxidative stress and apop-
tosis in neurons and mesangial cells (Sandau 
and Brüne, 2000). The other function of Bcl-
2 is antioxidative and prevention of apoptosis 
(Korsmeyer et al., 1995). One can conclude 
that increased ratio of Bax/Bcl-2 has im-
portant role in GM induced apoptosis of 
mesangial cells. 
Nitric oxide (NO) has vital function in lo-
cal regulation of blood flow in kidney cortex 
and can influence glomerular filtration. NO 
can act in different ways, acting as physiolog-
ical signal molecule, protector of cell func-
tions and toxic mediator (Valdivielso and 
Blantz, 2002). Cell damage mediated by NO 
is done through several mechanisms includ-
ing disturbance of mitochondrial respiration, 
inhibition of enzymes, nitrosylation of pro-
teins and lipid peroxidation by mediators like 
peroxynitrite produced in reaction between 
NO and O2-. This reaction happens when high 
concentration of NO become available as a re-
sult of increased activity of inducible NO syn-
thase (iNOS) (Gordge, 1998). We can assume 
that increased expression of iNOS and pro-
duction of NO has a role in apoptosis of 
mesangial cells in vitro (Martinez-Salgado et 
al., 2004). So, in vitro studies have shown that 
GM increase synthesis of iNOS messenger 
RNA in mesangial cells together with produc-
tion of NO, and that NO has antiproliferative 
role in these cells treated with GM (Rivas-
Cabanero et al., 1997). In apoptosis of mesan-
gial cells mediated by high intracellular cal-
cium, NO acts as proapoptotic factor 
(Rodríguez-López et al., 1999). Brüne (2002) 
has reported that proapoptotic effect of NO on 
mesangial cells is partially mediated by acti-
vation of Jun N-terminal kinase (JNK). Even 
though the increased production of NO has 
more effect on apoptosis then on prolifera-
tion, the created O2- as a result of stimulation 
of NO synthase could lead to proliferation of 
mesangial cells (Martinez-Salgado et al., 
2002). One should have in mind that both 
contraction and proliferation of mesangial 
cells in culture after treatment with GM are 
happening in artificial conditions without 
many in vivo neuroendocrine stimuli and cell-
matrix interactions. That is why interpretation 
of in vitro results should be taken with cau-
tion. Generally, stimuli that cause in vitro 
contraction have similar effects in vivo. How-
ever, the proliferation process is more com-
plex. Many stimuli are capable of inducting 
proliferation, apoptosis or other effects de-
pending of specific conditions of the cell.  
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There are numerous data about ability of 
calcium channel blockers to inhibit contrac-
tion and proliferation of mesangial cells in-
duced by different agents (Montero et al., 
1995). Increase in free cytosolic calcium 
(Ca2+) is necessary for both processes in those 
cells. GM increase intracellular Ca2+ by stim-
ulating entry of extracellular calcium and 
through releasing of internal depots (Mar-
tinez-Salgado et al., 2000). Calcium channel 
blocker verapamil decrease contraction and 
proliferation of mesangial cells induced by 
GM, which proves that increase in intracellu-
lar calcium has important role in contractile 
and proliferative effects of GM (Martinez-
Salgado et al., 2000). During development of 
GM nephrotoxicity, the increased calcium 
concentration activates phospholipases, nu-
cleases and proteases which disrupts the func-
tion of cell membrane and contribute to fur-
ther damage. The protective effect of vera-
pamil is based on calcium entry inhibition. 
Verapamil reduce liberation of calcium from 
endoplasmic reticulum. This is how vera-
pamil reduce GM nephrotoxicity, which has 
redistribution of intracellular calcium in its 
core (Stojiljkovic et al., 2008).  
The role of ROS in tubular and glomerular 
effects of GM has been clearly demonstrated. 
In vivo, ROS are labeled as proximal tubule 
necrosis and acute kidney injury mediators 
(Du and Yang, 1994). Scavengers of ROS 
were found beneficial in attenuating kidney 
injury after application of GM (Randjelovic et 
al., 2012a). The application of antioxidants 
like SOD or dimethyl-thiourea prevented GM 
induced decrease of glomerular filtration 
(Nakajima et al., 1994). The application of 
SOD in rats treated with GM leads to in-
creased renal blood flow. This is why is con-
sidered that superoxide anion has some func-
tion in GM induced vasoconstriction 
(Nakajima et al., 1994). 
The role of ROS as physiological second 
messengers or inducers of oxidative stress is 
clearly evident in activation and injury of 
mesangial cells. There are reports that H2O2 is 
capable of inducing contraction of mesangial 
cells in vitro, as well as increase in preglomer-
ular resistance in vivo (Duque et al., 1992). In-
volvement of ROS in mesangial contraction 
and proliferation was demonstrated in vivo 
too. The application of GM leads to stimula-
tion of O2- and SOD activity. Also it was 
shown that intracellular ROS scavengers, 
SOD and catalase, inhibits GM induced 
mesangial proliferation and contraction (Mar-
tinez-Salgado et al., 2002). Similar trend was 
shown for natural antioxidant trans-resvera-
trol (Morales et al., 2005). The production of 
O2- caused by GM in this cells is partly medi-
ated by NADP(H) oxidase activity (Martinez-
Salgado et al., 2002). The other possible 
source of O2- could be activation of phospho-
lipase A2 (Pfeilschifter and Huwiler, 1994). 
This is important because GM can activate 
phospholipase A2 (Martinez-Salgado et al., 
1997). There are numerous experimental data 
pointing that ROS can activate a mechanism 
leading to proliferation of mesangial cells 
(Ali, 1995). Studies have confirmed that oxi-
dative stress caused by application of xan-
thine with xanthine oxidase stimulates apop-
tosis of mesangial cells in culture, while addi-
tion of SOD and catalase in the medium pre-
vents this effect (Martinez-Salgado et al., 
2004).  
In rats treated with GM the proliferation 
and apoptosis process are happening at the 
same time. Obviously there is mutual com-
pensation, because there was not shown any 
change in the number of cells in mesangium 
(Martinez-Salgado et al., 2004). There were 
no studies showing a change in the number of 
mesangial cells after GM treatment till 2013, 
when first data become available about the 
GM-induced increase in mesangial cell num-
ber (Randjelovic, 2013). Our group of authors 
has shown that application of GM to rats is 
followed by increase in the size of glomeruli 
without the change in cellular density. A con-
clusion from such data was that there was an 
increase in cell number as well. This opens a 
new perspective in this area and calls for fur-
ther research. With the advance of new and 
unused methods, we should reexamine old 
data about GM induced proliferation and 
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apoptosis in kidney. Mesangial proliferation 
is mediated by stimulation of ROS and NO 
production (Martinez-Salgado et al., 2005). 
GM stimulates expression of iNOS and NO 
production in isolated glomerulus and mesan-
gial cells (Leung et al., 2004). The increase in 
available NO during the course of oxidative 
stress can react with superoxide anion and 
peroxynitrite can be created. The created per-
oxynitrite is further creating nitrosative stress 
and cytotoxicity (Pedraza-Chaverri et al., 
2004). The precise role of balance between 
apoptosis and proliferation in mesangium is 
not clear so far. Probably one is a homeostatic 
consequence of the other. The primary effect 
in vivo would be apoptosis with following 
proliferation (Martinez-Salgado et al., 2007).  
 
Vascular effects 
 The application of GM is followed by de-
crease in renal blood flow as a result of in-
creased vascular resistance and not decreased 
perfusion pressure (Morales et al., 2002). A 
drop in blood flow through the kidney result 
in decrease in glomerular filtration and avail-
able oxygen and ATP in tubules (Parsons et 
al., 1997). In the beginning, the decrease in 
blood flow is a result of activation of tubu-
loglomerular feedback loop due to disturb-
ance in tubular reabsorption, in order to pre-
vent loss of fluid and electrolytes. Later on, 
after adaptation of this physiological mecha-
nism, the flow is reduced because of vasocon-
strictors production in renal blood vessels as 
well as by direct effect of GM on vascular 
cells. Nitric oxide produced in small quanti-
ties is important for physiological vasodilata-
tion, while overproduction of NO due to over-
expression of iNOS is causing cytotoxic ef-
fects. Nitric oxide is reacting with superoxide 
anion and peroxynitrite is formed, damaging 
proteins and cells. In such scenario, the 
formed peroxynitrite is turning endothelial 
NO synthase into dysfunctional enzyme 
which creates superoxide and contribute to 
vascular oxidative stress (Forstermann, 
2010). GM also interfere with relaxation of 
vascular smooth muscle cells, probably by 
stimulating vasoconstriction and reducing re-
nal blood flow (Seçilmiş et al., 2005). How-
ever, it was shown that GM can relax isolated 
precontracted arteries by inhibition of phos-
pholipase C, protein kinase C and blocking of 
calcium channels (Wickman et al., 2001). GM 
can induce leucocyte margination in retinal 
blood vessels leading to congestion and in-
farct. The observed effect is seen 48 to 72 
hours after treatment (Hines et al., 1993). It 
can be assumed that similar could happen in 
kidney, especially in proinflammatory envi-
ronment. It is assumed that GM nephrotoxi-
city is primarily tubulopathy where tubular 
damage and dysfunction are main reasons for 
kidney failure. This can explain some clinical 
manifestations like proteinuria, enzymuria 
and electrolyte disbalance. However, in the 
absence of tubular obstruction, the sole tubu-
lar damage is insufficient for observed re-
duced glomerular filtration without additional 
extratubular events. Failure of tubular func-
tion leads to fluid and electrolytes loss which 
activates tubuloglomerular feedback loop, re-
ducing blood flow and filtration.  
 
Oxidative stress 
The treatment with GM produces oxida-
tive stress in cells of the tubules, both in vivo 
and in culture (Karatas et al., 2004; Juan et al., 
2007). The present oxidative stress is medi-
ated by hydroxyl radicals from H2O2 and su-
peroxide anion (Basnakian et al., 2002). It is 
considered that oxidative stress has central 
role in GM induced nephrotoxicity (Abdel-
Naim et al., 1999). Such opinion is backed up 
with numerous experiments showing that co-
treatment with different antioxidants protects 
from kidney damage induced by GM 
(Stojiljkovic et al., 2012; Randjelovic et al., 
2012a, b). However, some authors have 
shown that supplementation with glutathione 
(GSH) did not influence GM nephrotoxicity, 
regardless of decrease in lipid peroxidation 
and increase in level of GSH in kidney. GM 
directly increase production of ROS in mito-
chondria (Morales et al., 2010). The created 
ROS inhibits respiratory chain and ATP pro-
duction, stimulate release of cytochrome C 
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and other proapoptotic factors, disturb cell 
function by damaging cellular proteins, lipids 
and nucleic acids, induce mesangial contrac-
tion, leads to endoplasmic reticulum stress, 
are involved in inflammation and inhibits 
transmembrane sodium transport causing cell 
swelling and necrosis. As stated earlier, pro-
duced NO by iNOS can react with superoxide 
anion and form peroxynitrite, highly reactive 
radical which damage the cell. Probably is the 
protective effect of antioxidants a result of 
joined action at different levels: attenuating 
cytotoxic effect of GM, inhibition of vasocon-
striction and contraction of mesangium, anti-
inflammatory effect. However, there is little 
information about the effect of antioxidants 
on cytotoxic effect of GM on cells of tubules 
in culture. Juan et al. (2007) reported protec-
tive effect in similar conditions. They showed 
that tetrametilpirazin decrease accumulation 
of ROS and apoptosis in cells of rat kidney 
NFK-2E. 
 
CONCLUSION 
Gentamicin induced nephrotoxicity has 
been extensively studied in the past and has 
become one of the established models of drug 
induced nephrotoxicity. However, there are 
still controversies and speculation about the 
precise mechanism of action. There are par-
ticularly unclear results about apoptosis and 
proliferation in glomeruli in gentamicin in-
duced kidney damage. Here we tried to pre-
sent current knowledge and some recent up-
dates about balance between apoptosis and 
proliferation in glomeruli that shed new light 
into this model. This review can be used as a 
guide for everyone trying to understand and 
further investigate every aspect of gentamicin 
nephrotoxicity. Also potential readers could 
use presented ideas as a guide for their own 
future research. 
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